The combination of CJC-1295 (without DAC) and Ipamorelin represents one of the most studied growth hormone secretagogue blends in endocrinology research. By targeting both the GHRH and GHRP receptors simultaneously, this combination produces a synergistic amplification of growth hormone release that far exceeds either compound alone.
What is CJC-1295?
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH). The "w/o DAC" variant has a half-life of approximately 30 minutes, making it suitable for research protocols that mimic natural pulsatile GH release patterns. It works by binding to GHRH receptors in the anterior pituitary, stimulating growth hormone production and release.
What is Ipamorelin?
Ipamorelin is a synthetic pentapeptide classified as a selective growth hormone secretagogue. It acts as a ghrelin mimetic, binding to the GHS-R1a receptor to stimulate GH release. Unlike other GHRPs, Ipamorelin is highly selective — it stimulates GH release without significantly affecting cortisol, prolactin, or ACTH levels, earning it the reputation as the "cleanest" GHRP in research contexts.
The GHRH + GHRP Synergy
The combination works through complementary pathways that produce a synergistic effect on GH release. CJC-1295 stimulates the pituitary to produce GH via GHRH receptors (the "production" signal). Ipamorelin amplifies the GH pulse by activating ghrelin receptors and suppressing somatostatin (the hormone that inhibits GH release). Research demonstrates that combining a GHRH analog with a GHRP produces 3-5x greater GH release than either compound alone.
Research Applications
Body Composition Research
Studies examining elevated GH effects on body composition show impacts on lipolysis, protein synthesis, and nitrogen retention. Research models demonstrate changes in lean mass and fat mass ratios under controlled protocols.
Recovery and Repair
Growth hormone plays a critical role in tissue repair, collagen synthesis, and bone metabolism. Research protocols examine how amplified natural GH pulses affect recovery timelines in musculoskeletal injury models.
Sleep Architecture
GH is naturally released during deep (slow-wave) sleep. Research has examined the relationship between GH secretagogues and sleep quality, including impacts on slow-wave sleep duration.
Conclusion
The CJC-1295 + Ipamorelin blend represents the gold standard in dual-pathway growth hormone research. Researchers can study amplified, natural-pattern GH release and its effects on body composition, recovery, and metabolic function in controlled laboratory settings.
Source Research-Grade CJC-1295 w/o DAC + Ipamorelin
AltPeptide offers CJC-1295 w/o DAC + Ipamorelin in multiple research-grade formulations. All products are third-party assayed, lyophilized for stability, and shipped with DDP worldwide delivery.
All compounds are sold for laboratory research purposes only. Not for human or animal consumption.
All compounds mentioned are sold for in-vitro laboratory research only. Not for human or animal consumption. Not approved by FDA or any regulator for therapeutic use. This article is for educational and informational purposes only.